Redcare Pharmacy NV reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was EUR 1,267.44 million compared to EUR 876.52 million a year ago. Net loss was EUR 6.46 million compared to EUR 67.88 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.5 EUR | -9.13% | -11.48% | -16.79% |
26/04 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
26/04 | REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating | ZD |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.79% | 2.42B | |
-30.37% | 15.68B | |
-20.97% | 12.39B | |
-22.41% | 6.74B | |
-6.03% | 6.29B | |
+11.76% | 6.26B | |
+70.00% | 4.95B | |
-1.90% | 4.7B | |
-5.58% | 4.03B | |
-7.87% | 3.62B |
- Stock Market
- Equities
- RDC Stock
- News Redcare Pharmacy NV
- Redcare Pharmacy NV Reports Earnings Results for the Nine Months Ended September 30, 2023